Pet nutraceuticals delivered by gel strip (oral thin film, OTF) technology. Partnering with the leader in oral thin film technology for pharma, we are set to develop four different items for launch in 2025. These four items are joint and mobility, allergy and skin, calming, and vitamin and probiotic. We sell these items to vets, pet stores and online thru Amazon and Chewy. Oral Thin Film technology is superior to oral dissolving tablets because the active pharma ingredient (API) travels directly to the blood stream thru the gums, saliva and tongue instead of dissolving and be absorbed thru the gastric channel. Rejection by the dog, cat or horse is thereby minimized. Rejection by the pet is the problem. Gel Strip (OTF) is the solution. The market for this product is already huge and growing. The Pet Nutraceutical market is $6.8 billion worldwide with $2.7 billion in the US alone. The market is fragmented with large multicategory competitors along with smaller entities. Existing pet nutraceutical competitors have not adopted the OTF technology because it has not yet become a standard or important part of the human nutraceutical market. However, for pharma it is becoming more and more important. Our partner, Aquestive Therapeutics, is the leader in oral thin film pharma production. They hold the largest number of patents in the OTF category.
The team initially consists of Eric Weber and BSM Partners. Eric is a 17 year pet industry veteran and expert in online and brick and mortar sales and marketing, Eric started in the pet food business with Nestle where he ran Fancy Feast and Friskies Buffet brands and started up the Japan Friskies pet care business. Eric launched and sold a pet food business centered around the Petite Cuisine brand. He is currently consulting for Richell USA, a pet products company in the gates, crates, and litter box businesses. BSM Partners, who is the one stop shop for product formulation, label and other regulatory compliance, product testing and more, will be the product development arm of the company. BSM will work actively with Aquestive to develop the four items planned. Advisors to the company include David Levy, a pet industry veteran with numerous start up and mid level industry assignments. David ran and sold Zeus and Co, a large pet distributor in the Midwest. Also advising the company is John Nackel, CEO of Wavemaker 360 advisory group, a health care venture and management consulting group. John is the former worldwide head of Ernst and Young's healthcare practice and a past investor in Petite Cuisine.
Ready to Ask For Funding for your company?
Post a Funding Request